Clinical Trial Update: Infliximab IBD Influenza Vaccine Study [NA]

View source ↗

Summary

A completed study assessed infliximab in inflammatory bowel disease in conjunction with an influenza vaccine; the update does not provide trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Drugs mentioned

• Influenza vaccine (influenza vaccine)
• Remicade (infliximab)

Snippet

Sponsor: University of Calgary | Conditions: Inflammatory Bowel Disease | NA | Status: COMPLETED